A Phase II, Randomized, Placebo-controlled, Double-blind, Multiple Dose Study to Evaluate the Efficacy and Safety of ANB019 in Subjects With Palmoplantar Pustulosis
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Aug 2018
At a glance
- Drugs ANB 019 (Primary)
- Indications Palmoplantar pustulosis
- Focus Therapeutic Use
- Acronyms POPLAR
- Sponsors AnaptysBio
- 13 Aug 2018 Status changed from planning to not yet recruiting.
- 07 Aug 2018 According to an AnaptysBio media release, top line data from this study is anticipated in the second half of 2019.
- 19 May 2017 New trial record